Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension
- PMID: 8244517
- DOI: 10.1161/01.hyp.22.6.853
Effects of angiotensin II and endothelin-1 on platelet aggregation and cytosolic pH and free Ca2+ concentrations in essential hypertension
Abstract
The aims of this study were to determine the relations between platelet free calcium concentrations ([Ca2+]i), intracellular pH (pHi), and aggregation and to assess the effects of angiotensin II (Ang II) and endothelin-1 on these platelet parameters in normotensive subjects and hypertensive patients. Seventeen normotensive subjects, 25 untreated hypertensive patients, and 34 treated hypertensive patients were studied. Platelet cytosolic free [Ca2+]i and pHi were measured spectrofluorometrically using specific fluorescent probes (fura 2-AM and BCECF-AM, respectively) in unstimulated and Ang II- and endothelin-1-stimulated platelets. Aggregation was measured by a turbidometric technique. Basal [Ca2+]i (141 +/- 11 nmol/L) and pH (7.16 +/- 0.01) were higher (P < .05) in the untreated hypertensive group compared with the normotensive (118 +/- 9 nmol/L, 7.11 +/- 0.01, respectively) and treated hypertensive (121 +/- 11 nmol/L, 7.12 +/- 0.01, respectively) groups. In the combined normotensive and hypertensive groups, there were significant correlations between [Ca2+]i and mean arterial pressure (r = .75, P < .01), pHi and mean arterial pressure (r = .72, P < .01), [Ca2+]i and pHi (r = .71, P < .01), [Ca2+]i and aggregation (r = .69, P < .02), and pHi and aggregation (r = .56, P < .05). Ang II stimulation significantly increased [Ca2+]i and pHi in the untreated hypertensive and normotensive groups. The net change in [Ca2+]i induced by Ang II was significantly higher (P < .05) in the untreated hypertensive group compared with the other groups (67 +/- 6 nmol/L for the untreated hypertensive group versus 54 +/- 5 and 29 +/- 8 nmol/L for the normotensive and treated hypertensive groups, respectively). In the presence of Ang II, thrombin-induced aggregatory responses were increased in all three groups, but the maximal response was significantly higher in the untreated hypertensive group compared with the other groups (P < .05). Endothelin-1 increased pHi through endothelin A-receptors (effect blocked by the specific antagonist BQ-123) but had no significant effect on [Ca2+]i or aggregation. However, endothelin-1 blunted thrombin-induced platelet aggregation in normotensive subjects but not in hypertensive patients. In conclusion, increased Ang II-stimulated [Ca2+]i and pHi in platelets of essential hypertensive patients may be associated with increased aggregatory responses. The stimulatory effect of endothelin-1 on pHi but not on [Ca2+]i or aggregation suggests that in platelets endothelin-induced signaling pathways other than phospholipase C may be involved.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.J Hypertens. 1994 Nov;12(11):1255-63. J Hypertens. 1994. PMID: 7868873
-
The effect of angiotensin II on platelet intracellular free magnesium and calcium ionic concentrations in essential hypertension.J Hypertens. 1993 May;11(5):551-8. doi: 10.1097/00004872-199305000-00011. J Hypertens. 1993. PMID: 8390527
-
In vitro inhibition by endothelins of thrombin-induced aggregation and Ca2+ mobilization in human platelets.Br J Pharmacol. 1992 Aug;106(4):966-71. doi: 10.1111/j.1476-5381.1992.tb14443.x. Br J Pharmacol. 1992. PMID: 1393294 Free PMC article.
-
Blood platelets in human essential hypertension.Agents Actions. 1986 Aug;18(5-6):563-80. doi: 10.1007/BF01964966. Agents Actions. 1986. PMID: 3532721 Review.
-
Adrenoceptors on blood cells in patients with primary hypertension: correlation with blood pressure and related variables.J Hypertens. 1993 Sep;11(9):995-1002. doi: 10.1097/00004872-199309000-00015. J Hypertens. 1993. PMID: 8254183 Review.
Cited by
-
Valsartan decreases platelet activity and arterial thrombotic events in elderly patients with hypertension.Chin Med J (Engl). 2015 Jan 20;128(2):153-8. doi: 10.4103/0366-6999.149185. Chin Med J (Engl). 2015. PMID: 25591555 Free PMC article. Clinical Trial.
-
Role of the angiotensin II receptor blocker valsartan in heart failure.Exp Clin Cardiol. 2001 Winter;6(4):215-21. Exp Clin Cardiol. 2001. PMID: 20428262 Free PMC article.
-
Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost.Biochem Pharmacol. 2020 Aug;178:114057. doi: 10.1016/j.bcp.2020.114057. Epub 2020 May 27. Biochem Pharmacol. 2020. PMID: 32470547 Free PMC article. Review.
-
Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.Br J Pharmacol. 1995 Jan;114(2):524-30. doi: 10.1111/j.1476-5381.1995.tb13258.x. Br J Pharmacol. 1995. PMID: 7881751 Free PMC article.
-
Monocytes as immune targets in arterial hypertension.Br J Pharmacol. 2019 Jun;176(12):1966-1977. doi: 10.1111/bph.14389. Epub 2018 Jul 14. Br J Pharmacol. 2019. PMID: 29885051 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous